Built To Fail: How Today's Manufacturing Options Leave Pharma At Risk
Source: Thermo Fisher Scientific
By Joe Principe, Vice President, Strategic Partnerships, Thermo Fisher Scientific
By Joe Principe, Vice President, Strategic Partnerships, Patheon
When planning for the development of a new product, a pharmaceutical manufacturer must determine very early in the process what a product’s anticipated demand will be at the time of launch. Not only is this very difficult to do, but also the consequences of incorrect forecasts can be very costly in a number of ways. Without the ability to predict capacity needs with 100% accuracy, pharma must come up with an effective way to eliminate demand risks.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma
Thermo Fisher Scientific
This website uses cookies to ensure you get the best experience on our website. Learn more